{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:57:04Z","timestamp":1791619024147,"version":"4.3.4"},"reference-count":217,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000620-02"],"award-info":[{"award-number":["Z1A DA000620-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neubiorev.2020.04.024","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T19:58:05Z","timestamp":1588535885000},"page":"38-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges"],"prefix":"10.1016","volume":"114","author":[{"given":"Ewa","family":"Galaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2020.04.024_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0006-8993(02)02242-4","article-title":"Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions","volume":"930","author":"Abbadie","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0010","article-title":"Use of atypical antipsychotics and risk of hypertension: a case report and review literature","volume":"7","author":"Alves","year":"2019","journal-title":"SAGE Open Med. Case Rep."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0091-3057(85)90014-0","article-title":"Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat","volume":"23","author":"Amalric","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0020","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1021\/jm500801r","article-title":"Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity","volume":"57","author":"Ananthan","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/jpet.115.224121","article-title":"Dopamine D3 receptor antagonist (GSK598809) potentiates the hypertensive effects of cocaine in conscious, freely-moving dogs","volume":"354","author":"Appel","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/syn.10188","article-title":"Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats","volume":"48","author":"Ashby","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008877-200505000-00007","article-title":"The dopamine D(3) receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats","volume":"16","author":"Aujla","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/00498250110056531","article-title":"Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro\/in vivo correlation and the role of aldehyde oxidase","volume":"31","author":"Austin","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrn3104","article-title":"Opiate versus psychostimulant addiction: the differences do matter","volume":"12","author":"Badiani","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(25)10296-6","article-title":"Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats","volume":"264","author":"Bals-Kubik","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0055","doi-asserted-by":"crossref","first-page":"14094","DOI":"10.1523\/JNEUROSCI.3370-12.2012","article-title":"Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions","volume":"32","author":"Barrot","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.abb.2005.10.027","article-title":"Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling","volume":"446","author":"Basile","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200102000-00001","article-title":"The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered","volume":"12","author":"Beardsley","year":"2001","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0070","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Phys."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0075","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145712000661","article-title":"Modification of cocaine self-administration by buspirone (buspar\u00ae): potential involvement of D3 and D4 dopamine receptors","volume":"16","author":"Bergman","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0080","first-page":"95","article-title":"Dopamine in the brain: hypothesizing surfeit or deficit links to reward and addiction","volume":"1","author":"Blum","year":"2015","journal-title":"J. Reward Defic. Syndrome"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0085","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1021\/acs.jmedchem.5b00776","article-title":"High affinity dopamine D3 receptor (D3R)-selective antagonists attenuate heroin self-administration in wild-type but not D3R knockout mice","volume":"58","author":"Boateng","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0090","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1523\/JNEUROSCI.4371-11.2012","article-title":"Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study","volume":"32","author":"Boileau","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","article-title":"Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA","volume":"564","author":"Bouthenet","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0024-3205(81)90148-X","article-title":"Intracranial self-administraion of morphine into the ventral tegmental area in rats","volume":"28","author":"Bozarth","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0105","first-page":"62","article-title":"Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord","volume":"8","author":"Brewer","year":"2014","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0110","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2215\/CJN.11121017","article-title":"Self-reported tobacco, alcohol, and illicit drug use and progression of chronic kidney disease","volume":"13","author":"Bundy","year":"2018","journal-title":"CJASN"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0115","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.jcp.0000162804.38829.97","article-title":"Efficacy of buspirone in the treatment of opioid withdrawal","volume":"25","author":"Buydens-Branchey","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0120","series-title":"CDC in Action: 2018 Response to the Opioid Crisis","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.biopsych.2016.12.022","article-title":"Mu opioid receptors in gamma-aminobutyric acidergic forebrain neurons moderate motivation for heroin and palatable food","volume":"81","author":"Charbogne","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2014.09.026","article-title":"A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats","volume":"743","author":"Chen","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0135","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","article-title":"Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist","volume":"330","author":"Chien","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0140","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s12272-010-1005-8","article-title":"Current perspectives on the selective regulation of dopamine D\u2082 and D\u2083 receptors","volume":"33","author":"Cho","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0145","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.1523\/JNEUROSCI.3698-04.2004","article-title":"Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice","volume":"24","author":"Clemens","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.15585\/mmwr.mm6802a3","article-title":"Overdose deaths involving fentanyl and fentanyl analogs - New York City, 2000\u20132017","volume":"68","author":"Colon-Berezin","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0155","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39945","article-title":"Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement","volume":"7","author":"Corre","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/qjmed\/93.3.147","article-title":"Substance abuse and the kidney","volume":"93","author":"Crowe","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0165","doi-asserted-by":"crossref","first-page":"17553","DOI":"10.3390\/ijms140917553","article-title":"Renal dopamine receptors, oxidative stress, and hypertension","volume":"14","author":"Cuevas","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nn.3622","article-title":"Targeted expression of \u03bc-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward","volume":"17","author":"Cui","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0180","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.addbeh.2007.01.014","article-title":"Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS)","volume":"32","author":"Darke","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-4328(94)90106-6","article-title":"A comparative study of self-administration of morphine into the amygdala and the ventral tegmental area in mice","volume":"65","author":"David","year":"1994","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s002130000425","article-title":"Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of mice","volume":"150","author":"David","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0195","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fnbeh.2019.00292","article-title":"Dopamine D3 receptor antagonism reverses the escalation of oxycodone self-administration and decreases withdrawal-induced hyperalgesia and irritability-like behavior in oxycodone-dependent heterogeneous stock rats","volume":"13","author":"de Guglielmo","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/347072a0","article-title":"Molecular cloning and expression of the gene for a human D1 dopamine receptor","volume":"347","author":"Dearry","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0205","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1523\/JNEUROSCI.14-04-01978.1994","article-title":"Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats","volume":"14","author":"Devine","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1037\/0735-7044.122.1.129","article-title":"Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala","volume":"122","author":"Di Ciano","year":"2008","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0215","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0306-4522(94)00527-C","article-title":"Phenotypical characterization of neurons expressing the dopamine D 3 receptor in the rat brain","volume":"65","author":"Diaz","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0220","series-title":"Control of a Chemical Precursor Used in the Illicit Manufacture of Fentanyl as a List I Chemical","author":"Drug Enforcement Administration","year":"2007"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0225","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.npp.1300276","article-title":"Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats","volume":"28","author":"Duarte","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0230","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pmn.2007.02.004","article-title":"Mechanisms of opioid-induced tolerance and hyperalgesia","volume":"8","author":"DuPen","year":"2007","journal-title":"Pain Manag. Nurs."},{"issue":"4","key":"10.1016\/j.neubiorev.2020.04.024_bib0235","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0091-3057(88)90138-4","article-title":"Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration. Aug","volume":"30","author":"Dworkin","year":"1988","journal-title":"Pharmacol Biochem Behav."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0240","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1096\/fasebj.29.1_supplement.614.5","article-title":"Efficacy of dopamine D3 receptor antagonist SR 21502 in reducing opioid tolerance and dependence","volume":"29","author":"Eon","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0245","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00429-014-0717-9","article-title":"A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks","volume":"220","author":"Erbs","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00428151","article-title":"Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems","volume":"78","author":"Ettenberg","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","article-title":"Understanding opioid reward","volume":"38","author":"Fields","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0260","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nn1103","article-title":"Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission","volume":"6","author":"Floresco","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0265","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/00001756-200410050-00021","article-title":"Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice","volume":"15","author":"Frances","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00213-004-1807-9","article-title":"Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference","volume":"175","author":"Frances","year":"2004","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2020.04.024_bib0275","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1460-9568.2010.07564.x","article-title":"Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector","volume":"33","author":"Fujiyama","year":"2011","journal-title":"Eur J Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0280","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00213-013-3254-y","article-title":"The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats","volume":"231","author":"Galaj","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0285","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2015.09.011","article-title":"The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats","volume":"156","author":"Galaj","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neubiorev.2018.03.020","article-title":"Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder","volume":"89","author":"Galaj","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0295","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1527-3458.2003.tb00246.x","article-title":"BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction","volume":"9","author":"Garcia-Ladona","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0300","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1152\/jn.2001.86.5.2183","article-title":"Modulatory actions of serotonin, norepinephrine, dopamine, and acetylcholine in spinal cord deep dorsal horn neurons","volume":"86","author":"Garraway","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/syn.1088","article-title":"Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area","volume":"41","author":"Garz\u00f3n","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0310","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF02249340","article-title":"Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat","volume":"114","author":"Gerrits","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/syn.20152","article-title":"Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors","volume":"57","author":"Gilbert","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0320","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0306-4522(97)00298-4","article-title":"Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour","volume":"82","author":"Goff","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0325","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(84)80036-4","article-title":"Dopamine receptors and hypertension. Physiologic and pharmacologic implications","volume":"77","author":"Goldberg","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semdp.2008.12.001","article-title":"Cocaine: history, social implications, and toxicity: a review","volume":"26","author":"Goldstein","year":"2009","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2011.04.004","article-title":"30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California","volume":"118","author":"Grella","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001756-200301200-00018","article-title":"Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference","volume":"14","author":"Gyertyan","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0350","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-8993(83)90913-7","article-title":"Morphine-induced activation of A10 dopamine neurons in the rat","volume":"277","author":"Gysling","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0355","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2014.03.055","article-title":"The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats","volume":"569","author":"Hachimine","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jpain.2016.10.001","article-title":"Inhibition of reinforcing, hyperalgesic, and motor effects of morphine by buspirone in rats","volume":"18","author":"Haleem","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2014.06.022","article-title":"Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum","volume":"1586","author":"Haleem","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2005.09.038","article-title":"Novel pharmacotherapeutic targets for the management of drug addiction","volume":"526","author":"Heidbreder","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0375","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/187152708786927822","article-title":"Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence","volume":"7","author":"Heidbreder","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0380","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","article-title":"Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"Heidbreder","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0385","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2011.02.046","article-title":"Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats","volume":"659","author":"Higley","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0390","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1523\/JNEUROSCI.0178-13.2013","article-title":"Opioid modulation of ventral pallidal afferents to ventral tegmental area neurons","volume":"33","author":"Hjelmstad","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0395","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature04172","article-title":"Morphine reward in dopamine-deficient mice","volume":"438","author":"Hnasko","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0400","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial","author":"Hser","year":"2015","journal-title":"Addiction"},{"issue":"13","key":"10.1016\/j.neubiorev.2020.04.024_bib0405","first-page":"00782","article-title":"The dopamine D3 receptor antagonist YQA14 that inhibits the expression and drug-primed reactivation of morphine-induced conditioned place preference in rats","author":"Hu","year":"2013","journal-title":"Eur J Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0410","doi-asserted-by":"crossref","first-page":"16446","DOI":"10.1073\/pnas.1105418108","article-title":"Neuronal circuits underlying acute morphine action on dopamine neurons","volume":"108","author":"Jalabert","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0415","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1373\/clinchem.2017.281626","article-title":"The fentanyl epidemic and evolution of fentanyl analogs in the United States and the European Union","volume":"65","author":"Jannetto","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0420","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.neuron.2009.02.001","article-title":"The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses","volume":"61","author":"Jhou","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0425","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cne.21891","article-title":"The mesopontine rostromedial tegmental nucleus: a structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta","volume":"513","author":"Jhou","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0430","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-012-2753-6","article-title":"Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat","volume":"224","author":"Jhou","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0435","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.015","article-title":"Progress in agonist therapy for substance use disorders: lessons learned from methadone and buprenorphine","author":"Jordan","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.003","article-title":"The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents","author":"Jordan","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0450","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.119.259390","article-title":"Newly-developed dopamine D3 receptor antagonists, R-VK4-40 and R-VK4-116, do not potentiate cardiovascular effects of cocaine or oxycodone in rats","author":"Jordan","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0455","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/10641969709080801","article-title":"Transgenic mice to study the role of dopamine receptors in cardiovascular function","volume":"19","author":"Jose","year":"1997","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0460","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1523\/JNEUROSCI.5530-09.2010","article-title":"Shared mechanisms for opioid tolerance and a transition to chronic pain","volume":"30","author":"Joseph","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0465","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-420118-7.00007-X","article-title":"Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design","volume":"69","author":"Keck","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0470","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1021\/jm501512b","article-title":"Identifying medication targets for psychostimulant addiction: unraveling the dopamine D3 receptor hypothesis","volume":"58","author":"Keck","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0475","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.expneurol.2012.09.002","article-title":"Increased excitability of spinal pain reflexes and altered frequency-dependent modulation in the dopamine D3-receptor knockout mouse","volume":"238","author":"Keeler","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0480","first-page":"66","article-title":"Physical effects of methadone maintenance treatment from the standpoint of clients","volume":"2","author":"Kheradmand","year":"2010","journal-title":"Addict. Health"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0485","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(97)00988-8","article-title":"Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene","volume":"778","author":"Kitchen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0490","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2007.9.2\/hkleber","article-title":"Pharmacologic treatments for opioid dependence: detoxification and maintenance options","volume":"9","author":"Kleber","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0495","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ajhp\/zxz105","article-title":"Medications for management of opioid use disorder","volume":"76","author":"Koehl","year":"2019","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0500","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1098\/rspb.1980.0122","article-title":"Characterization of opioid receptors in nervous tissue","volume":"210","author":"Kosterlitz","year":"1980","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0505","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02090784","article-title":"S-(+)-aporphines are not selective for human D3 dopamine receptors","volume":"14","author":"Kula","year":"1994","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0510","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/acs.jmedchem.6b00860","article-title":"Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: new leads for opioid dependence treatment","volume":"59","author":"Kumar","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0515","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.euroneuro.2014.08.017","article-title":"Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction","volume":"25","author":"Le Foll","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0520","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1046\/j.1460-9568.2002.02049.x","article-title":"Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice","volume":"15","author":"Le Foll","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0525","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/syn.10170","article-title":"Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats","volume":"47","author":"Le Foll","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0530","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-444-63425-2.00011-8","article-title":"Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings","volume":"211","author":"Le Foll","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0535","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/npp.2015.177","article-title":"Occupancy of dopamine D3 and D2 receptors by buspirone: a [11C]-(+)-PHNO PET study in humans","volume":"41","author":"Le Foll","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0540","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/npp.2011.302","article-title":"Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse","volume":"37","author":"Lecca","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0545","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0031-6997(24)01327-9","article-title":"The D3 dopamine receptor: neurobiology and potential clinical relevance","volume":"49","author":"Levant","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0550","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(01)01692-5","article-title":"D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function","volume":"303","author":"Levant","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0555","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.89.17.8155","article-title":"Identification, characterization, and localization of the dopamine D 3 receptor in rat brain using 7-[3 H]hydroxy- N, N -di- n -propyl-2-aminotetralin","volume":"89","author":"Levesque","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0560","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2010.09.025","article-title":"Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration","volume":"485","author":"Li","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0565","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainres.2011.11.045","article-title":"Role of dopamine D3 receptors in basal nociception regulation and in morphine-induced tolerance and withdrawal","volume":"1433","author":"Li","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0570","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41401-018-0153-0","article-title":"Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice","volume":"40","author":"Lv","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0575","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1530-0277.1996.tb01644.x","article-title":"Buspirone in the treatment of alcohol dependence: a placebo-controlled trial","volume":"20","author":"Malec","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0580","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1530-0277.1996.tb05263.x","article-title":"Efficacy of buspirone in alcohol dependence: a review","volume":"20","author":"Malec","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0585","first-page":"2445","article-title":"Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain","volume":"7","author":"Mansour","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0590","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1523\/JNEUROSCI.2144-14.2014","article-title":"Direct bidirectional \u03bc-opioid control of midbrain dopamine neurons","volume":"34","author":"Margolis","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0595","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1749-6632.1999.tb09286.x","article-title":"D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims","volume":"877","author":"Mash","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0600","doi-asserted-by":"crossref","first-page":"17729","DOI":"10.1523\/JNEUROSCI.4570-11.2011","article-title":"Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons","volume":"31","author":"Matsui","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0605","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0610","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0615","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2009.06.022","article-title":"A placebo-controlled trial of buspirone for the treatment of marijuana dependence","volume":"105","author":"McRae-Clark","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0620","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.08.013","article-title":"Buspirone treatment of cannabis dependence: a randomized, placebo-controlled trial","volume":"156","author":"McRae-Clark","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0625","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(92)90024-2","article-title":"Distribution of D5 dopamine receptor mRNA in rat brain","volume":"145","author":"Meador-Woodruff","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.neubiorev.2020.04.024_bib0630","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0168-0102(03)00188-3","article-title":"Acute ethanol administration transiently decreases [3H]-DAMGO binding to mu opioid receptors in the rat substantia nigra pars reticulata but not in the caudate-putamen. Oct","volume":"47","author":"M\u00e9ndez","year":"2003","journal-title":"Neurosci Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0635","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"MERRER","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0640","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/npp.2008.111","article-title":"The ventral pallidum is critically involved in the development and expression of morphine-induced sensitization","volume":"34","author":"Mickiewicz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0645","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0304-3959(88)90140-6","article-title":"Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat","volume":"35","author":"Millan","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0650","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3565(25)12142-3","volume":"275","author":"Millan","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0655","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0022-3565(25)24555-4","article-title":"Elctrophysiological demonstration of u, s, and k opiod receptors in the ventral pallidum","volume":"272","author":"Mitrovic","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0660","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/FBP.0b013e3283566a4a","article-title":"Effect of dopamine D\u2083 receptor antagonism on approach responses to food cues in overweight and obese individuals","volume":"23","author":"Mogg","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0665","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0670","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/npp.2012.171","article-title":"Occupancy of brain dopamine D3 receptors and drug craving: a translational approach","volume":"38","author":"Mugnaini","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0675","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1523\/JNEUROSCI.23-03-01006.2003","article-title":"Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion","volume":"23","author":"Narita","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0680","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S1461145711001052","article-title":"The effects of the dopamine D\u2083 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects","volume":"15","author":"Nathan","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0685","first-page":"201","article-title":"Buspirone attenuates tolerance to analgesic effect of morphine in mice with skin cancer","volume":"23","author":"Nayebi","year":"2010","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0690","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.npp.1300456","article-title":"Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior","volume":"29","author":"Neisewander","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0695","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0960-894X(03)00389-5","article-title":"N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists","volume":"13","author":"Newman","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0700","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1021\/jm040190e","article-title":"Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents","volume":"48","author":"Newman","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0705","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1021\/jm900095y","article-title":"N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists","volume":"52","author":"Newman","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0710","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bcp.2012.06.023","article-title":"Medication discovery for addiction: translating the dopamine D3 receptor hypothesis","volume":"84","author":"Newman","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0715","series-title":"Trends and Statistics [WWW Document]","author":"NIDA","year":"2016"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0720","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011117.pub2","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0725","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.vascn.2014.03.002","article-title":"Functional binding assays for estimation of the intrinsic efficacy of ligands at the 5-HT1A receptor: application for screening drug candidates","volume":"70","author":"No\u00ebl","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0730","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/aje\/kws284","article-title":"Characterizing durations of heroin abstinence in the California civil Addict Program: results from a 33-year observational cohort study","volume":"177","author":"Nosyk","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0735","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The dopamine theory of addiction: 40 years of highs and lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0740","first-page":"137","article-title":"The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system","volume":"4","author":"O\u2019Malley","year":"1992","journal-title":"New Biol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0745","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0006-8993(82)90454-1","article-title":"Reinforcing effect of morphine in the nucleus accumbens","volume":"237","author":"Olds","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0750","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1037\/0735-7044.111.6.1324","article-title":"The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites","volume":"111","author":"Olmstead","year":"1997","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0755","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/syn.20345","article-title":"Topographical organization of GABAergic neurons within the ventral tegmental area of the rat","volume":"61","author":"Olson","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0760","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/S1461145706006560","article-title":"The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions","volume":"9","author":"Pak","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0765","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0024-3205(86)90217-1","article-title":"Multiple mu opiate receptors","volume":"38","author":"Pasternak","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0770","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.neuropharm.2008.12.007","article-title":"The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats","volume":"56","author":"Peng","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0775","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00427441","article-title":"Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats","volume":"84","author":"Pettit","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0780","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0091-3057(80)90460-8","article-title":"Reinforcing effects of morphine microinjection into the ventral tegmental area","volume":"12","author":"Phillips","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0785","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/22560","article-title":"Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist","volume":"400","author":"Pilla","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0790","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2014.10.018","article-title":"Impairment of acquisition of intravenous cocaine self-administration by RNA-interference of dopamine D1-receptors in the nucleus accumbens shell","volume":"89","author":"Pisanu","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0795","first-page":"255","article-title":"Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats","volume":"5","author":"Powell","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0800","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41386-018-0292-5","article-title":"NIDA\u2019s medication development priorities in response to the Opioid Crisis: ten most wanted","volume":"44","author":"Rasmussen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0805","first-page":"533","article-title":"Expression of mu-opioid receptors in developing rat spinal cord: an autoradiographic study","volume":"42","author":"Ray","year":"2004","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0810","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-3565(24)39184-0","article-title":"Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A","volume":"294","author":"Reavill","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0815","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1521-0391.2003.tb00653.x","article-title":"Effects of buspirone in withdrawal from opiates","volume":"12","author":"Rose","year":"2003","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0820","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2007.01.004","article-title":"Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats","volume":"559","author":"Ross","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0825","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths \u2013 United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0830","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0009-9236(96)90153-8","article-title":"Efficacy of buspirone in smoking cessation: a placebo-controlled trial","volume":"60","author":"Schneider","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0835","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0169-328X(97)00025-9","article-title":"Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities","volume":"45","author":"Segal","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0840","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.1021\/acs.jmedchem.9b00607","article-title":"Investigation of novel primary and secondary pharmacophores and 3-substitution in the linking chain of a series of highly selective and bitopic dopamine D3 receptor antagonists and partial agonists","volume":"62","author":"Shaik","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0845","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0850","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF03033202","article-title":"The dopamine D3 receptor and drug addiction","volume":"3","author":"Sokoloff","year":"2001","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0855","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose - Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0860","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1369-1600.2011.00317.x","article-title":"YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice","volume":"17","author":"Song","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0865","doi-asserted-by":"crossref","first-page":"17675","DOI":"10.1073\/pnas.1205297109","article-title":"Increased vulnerability to cocaine in mice lacking dopamine D3 receptors","volume":"109","author":"Song","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0870","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2013.04.042","article-title":"Dopamine D3 receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice","volume":"72","author":"Song","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0875","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2013.10.010","article-title":"Blockade of D3 receptors by YQA14 inhibits cocaine\u2019s rewarding effects and relapse to drug-seeking behavior in rats","volume":"77","author":"Song","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0880","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0169-328X(02)00671-X","article-title":"Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine","volume":"111","author":"Spangler","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0885","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-007-0986-6","article-title":"The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats","volume":"196","author":"Spiller","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0890","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996","article-title":"Adaptive increase in d 3 dopamine receptors in the brain reward circuit of human cocaine fatalities","volume":"16","author":"Staley","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.04.006","article-title":"Supplemental morphine infusion into the posterior ventral tegmentum extends the satiating effects of self-administered intravenous heroin","volume":"134","author":"Steidl","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0900","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2017.09.022","article-title":"Opioid-induced rewards, locomotion, and dopamine activation: a proposed model for control by mesopontine and rostromedial tegmental neurons","volume":"83","author":"Steidl","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0905","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/jm000090i","article-title":"Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): a potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat","volume":"43","author":"Stemp","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0910","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0915","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuron.2012.02.015","article-title":"GABA neurons of the VTA drive conditioned place aversion","volume":"73","author":"Tan","year":"2012","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.neubiorev.2020.04.024_bib0920","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1073\/pnas.84.12.4308","article-title":"Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Jun","volume":"84","author":"Tempel","year":"1987","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0925","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pharmthera.2013.02.002","article-title":"Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension","volume":"138","author":"Thomas","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0930","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S1461145708008778","article-title":"A role for dopamine D1-like receptors in acute food deprivation-induced reinstatement of heroin seeking in rats","volume":"12","author":"Tobin","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0935","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.1973.04200020065009","article-title":"A 20-year follow-up of New York narcotic addicts","volume":"29","author":"Vaillant","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0940","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2999(87)90172-5","article-title":"The dopamine hypothesis of opiate reward challenged","volume":"134","author":"van Ree","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0945","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.neuron.2012.02.016","article-title":"Activation of VTA GABA neurons disrupts reward consumption","volume":"73","author":"van Zessen","year":"2012","journal-title":"Neuron"},{"issue":"Apr 2","key":"10.1016\/j.neubiorev.2020.04.024_bib0950","article-title":"Collision of the COVID-19 and addiction epidemics","volume":"2020","author":"Volkow","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0955","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: a review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0960","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002","article-title":"Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats","volume":"22","author":"Vorel","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0965","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/acschemneuro.6b00297","article-title":"Dopamine D3\/D2 receptor antagonist PF-4363467 attenuates opioid drug-seeking behavior without concomitant D2 side effects","volume":"8","author":"Wager","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0970","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical review: opiate addiction and opioid receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0975","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/ejn.13237","article-title":"Muscarinic control of rostromedial tegmental nucleus GABA neurons and morphine-induced locomotion","volume":"44","author":"Wasserman","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0980","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neuron.2012.03.017","article-title":"Whole-brain mapping of direct inputs to midbrain dopamine neurons","volume":"74","author":"Watabe-Uchida","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0985","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1073\/pnas.88.5.1859","article-title":"D1 and D2 dopamine receptor mRNA in rat brain","volume":"88","author":"Weiner","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0990","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0028-3908(89)90112-3","article-title":"Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat","volume":"28","author":"Welzl","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib0995","series-title":"The White House. The Opioid Crisis","author":"White House","year":"2017"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1000","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(01)01054-8","article-title":"The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors","volume":"424","author":"Wicke","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4088\/JCP.13m08862","article-title":"Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence","volume":"75","author":"Winhusen","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(00)00732-9","article-title":"Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor","volume":"407","author":"Wood","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1527-3458.2007.00013.x","article-title":"Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction","volume":"13","author":"Xi","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1874473710801030303","article-title":"Hypothesis-driven medication discovery for the treatment of psychostimulant addiction","volume":"1","author":"Xi","year":"2008","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00213-004-1858-y","article-title":"Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats","volume":"176","author":"Xi","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1030","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/j.1460-9568.2005.04159.x","article-title":"Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats","volume":"21","author":"Xi","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1035","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.npp.1300912","article-title":"The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine\u2019s rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats","volume":"31","author":"Xi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1040","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1523\/JNEUROSCI.1504-11.2011","article-title":"Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area","volume":"21","author":"Xia","year":"2011","journal-title":"J Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.09.007","article-title":"The novel dopamine D3 receptor antagonists\/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats","volume":"126","author":"You","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1050","article-title":"Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects","author":"You","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1055","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/S0960-894X(98)00469-7","article-title":"NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists","volume":"8","author":"Yuan","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1060","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1523\/JNEUROSCI.22-16-07225.2002","article-title":"Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens","volume":"22","author":"Zangen","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1152\/physiolgenomics.00127.2004","article-title":"Functional genomics of the dopaminergic system in hypertension","volume":"19","author":"Zeng","year":"2004","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/ki.2008.247","article-title":"Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions","volume":"74","author":"Zeng","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2018.08.016","article-title":"Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice","volume":"141","author":"Zhan","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2010.04.049","article-title":"Dopamine D3 receptor regulates basal but not amphetamine-induced changes in pain sensitivity in mice","volume":"477","author":"Zhu","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2020.04.024_bib1085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccc.2012.07.003","article-title":"Cocaine intoxication","volume":"28","author":"Zimmerman","year":"2012","journal-title":"Crit. Care Clin."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763420303894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763420303894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:25:41Z","timestamp":1777490741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763420303894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":217,"alternative-id":["S0149763420303894"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2020.04.024","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2020.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}